Emergis renews its relationship with Great-West Life

Montréal, August 2, 2007 — Emergis Inc. (TSX: EME) today announced that it has renewed its service agreement with The Great-West Life Assurance Company, a leader in the group benefits marketplace. Under this new five-year contract, Great-West Life will continue to use Emergis' Assure Claims solution for the adjudication of its drug card claims and the transport of its electronic dental claims.

“We are pleased to continue our longstanding relationship with Emergis,” said Dave Johnston, Executive Vice-President of Great-West Life's Group Insurance Division. “Emergis continues to deliver the quality customer service and reliability that we need in the management of our claims processing.”

Emergis' Assure Claims solution makes it possible to adjudicate electronic claims in real time from the point of service on behalf of insurers such as Great-West, governments and their agencies. It allows for the management of information pertaining to each sponsor's group plan and claimants' eligibility, as well as the transmission of direct payment to health care professionals, and the reimbursement of claims submitted by group plan participants. Emergis' Assure Claims also provides a wide array of ancillary services such as formulary management, audits, fraud detection, data mining as well as professional services delivered by pharmacists and other industry experts.

“We view the five-year renewal by Great-West as a confirmation of our solid business relationship,” said François Côté, President and Chief Executive Officer of Emergis. “We are committed to providing best-in-class claims management services and working closely with our customers, both in the public and private sector, to evolve our services based on their input. We are also very focused on developing new adjudication functionality that will lead to more advanced claims processing systems.”

Insurer customers of Emergis collectively represent about half of the private group health insurance market in the country. In 2006, Emergis reached the 60 million mark for drug claims adjudicated. Emergis is also one of the largest electronic claims transport companies in Canada. In 2006, the company transported 158 million drug and dental claims. Its electronic network for the transport of claims reaches 99% of Canadian pharmacies and all dentists in Canada who submit claims electronically.

About Emergis
Emergis is an IT leader in Canada that focuses on the health and financial services sectors. It develops and manages solutions that automate transactions and the secure exchange of information to increase the process efficiency and quality of service of its customers. Emergis has expertise in electronic health-related claims processing, health record systems, pharmacy management solutions, cash management and loan document processing and registration. In Canada, Emergis delivers solutions to major insurance companies, top financial institutions, government agencies, hospitals, large corporations, real estate lawyers and notaries and 3,100 pharmacies. Its electronic health record solutions are also delivered in the U.S. and Australia. The Company's shares (TSX: EME) are included in the S&P/TSX Composite Index.

Certain information in this news release, in various filings with Canadian regulators, in reports to shareholders and in other communications, is forward-looking within the meaning of certain securi¬ties laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among others, information with respect to the Company's objectives and the strategies to achieve those objectives, as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions. The words “may”, “could”, “should”, “would”, “suspect”, “outlook”, “believe”, “anticipate”, “estimate”, “expect”, “intend”, “plan”, “target” and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of August 2, 2007.

The results or events predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from a conclusion, forecast or projection in such forward-looking information include, among others: general economic factors, adverse industry events, the adoption rate of the Company's solutions by customers and by related electronic trading communities, its ability to deliver development and implementation projects in a timely manner, the non-renewal of major contracts which expire in the near term, complexities and timing of signing large customer contracts, customers developing internally the capability to perform the services which the Company performs on their behalf, its response to its industry's rapid pace of change, the limited time to capitalize on market opportunities, competition, pricing pressures, fluctuations in its operating results, business dispositions, its ability to make and integrate acquisitions, failures or material changes in its strategic relationships, exposure under contract indemnities, defects in software or failures in the processing of transactions, security and privacy breaches, its ability to attract and retain key personnel, its ability to protect its intellectual property, intellectual property infringement claims, and industry and government regulation.

When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. In making the forward-looking information contained in this news release, the Company does not assume any significant acquisitions, dispositions or one-time items. It does assume, however, the renewal of certain customer contracts. Every year, Emergis has major customer contracts that it needs to renew. One of these represents slightly more than 10% of its annual revenue. In addition, the Company also assumes the signature of contracts in new markets in the public health sector. In this regard, Emergis is pursuing large opportunities that present a very long and complex sales cycle, which substantially affect the Company's forecasting abilities. The Company has made certain assumptions regarding the timing of the realization of these opportunities which it thinks is reasonable but which may not be achieved. Furthermore, the pursuit of these larger opportunities does not ensure a linear progression of the Company's revenue and earnings, since they may involve significant up-front fees followed by reduced ongoing payments. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not result in such forward-looking information differing materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. For additional information with respect to certain of these and other factors, refer to the risks and uncertainties section of the Company's 2006 MD&A and to its 2006 Annual Information Form (risks and uncertainties) filed with Canadian regulators.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF EMERGIS AS OF AUGUST 2, 2007 AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. HOWEVER, EMERGIS EXPRESSLY DISCLAIMS ANY INTENTION OR OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY APPLICABLE LAW.